Indegene Ltd was incorporated as Indegene Lifesystems Private Limited at Ahmedabad, Gujarat, as a Private Limited Company, datedOctober 16, 1998 at Ahmedabad. Subsequently, name of the Company was changed to Indegene Private Limited and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016. Thereafter, Company converted to a Public Company with change in name to Indegene Limited and a fresh certificate of incorporation was issued to Company by RoC, on November 17, 2022.The Company is a digitalfirst commercialization company focused exclusively on the global life sciences industry. Their solutionsenable biopharmaceutical, emerging biotech and medical devices companies develop products, launch them in the market, anddrive sales through their life cycle in a more effective, efficient and modern manner. Their portfolio of solutions cover all aspects ofcommercial, medical, regulatory and RD operations of life sciences companies. Their Enterprise Commercial Solutions (ECS) involve assisting life sciences companies with their digital marketing operations. Omnichannel Activation solutions help life sciences companies leverage a digital first approach for optimizing the lastmile promotion of biopharmaceutical products and medical devices to HCPs across multiple channels. Under Enterprise Medical Solutions, the Company establish centers of excellence (CoEs) to consolidate large scale regulatory and medical operations for their clients.Apart from these, the Company offer Enterprise Clinical Solutions and consultancy services, which help drive efficiencies in the drug discovery and clinical trial operations of life sciences companies. It bring in their expertise in data management and analyticsin helping biopharmaceutical companies seamlessly handle and analyze multiple sources of data during clinical trials and build a case for regulatory approvals.In 2016, the Company acquired Encima Group, Inc. in the United States, a company which provided marketing analytics and campaign execution solutions to several large life sciences companies. In 2019, it acquired a minority stake in DT Associates Research and Consulting Services Limited, a digital transformation and client experience consulting firm in UK, to expand their strategic consulting capabilities. In December 2020, it acquired a majority stake in DT Associates Limited.On 8 December, 2021 the Company has demerged its commercial software business pursuant to a Scheme of Arrangement for transfer of the Demerged Business to OT Services India Private Limited (Resulting Company), approved by the National Company Law Tribunal, Bengaluru Bench with Appointed Date, i.e., October 1, 2020, which became effective on December 30, 2021.The Company acquired Cult Health, a fullservice healthcare marketing agency for several life sciences brands, through its subsidiary, ILSL Holdings, Inc. on October 12, 2022.The Company is planning to raise capital from Public by raising Rs 950 crores through fresh issue and 36,291,497 Equity Shares through Offer For Sale.
How has Indegene Ltd [INDGN] shares performed in the past ?
The past 1-year return of Indegene Ltd [INDGN] share was 0. The Indegene Ltd [INDGN] share hit a 1-year low of Rs. 468.9 and a 1-year high of Rs. 659.7.
What is the Mutual Fund shareholding in Indegene Ltd?
The Mutual Fund Shareholding was 2.28% at the end of .
How can I buy Indegene Ltd shares?
You can easily buy Indegene Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.